In accessing the Preliminary Placement Document, you agree to be bound by the following terms and conditions, including any modifications to them from time to time. Prestige Consumer Healthcare Inc. (formerly Prestige Brands, Inc.) markets, sells, manufactures and distributes consumer healthcare products to retail outlets in the US, Canada, Australia and certain international markets. Ranging from 1 Bedroom Units to Luxury 4 Bedroom Units, you’ll find it all here.Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“LODR”), we wish to inform you that a Meeting of the Board of Directors of Prestige Estates Projects Limited (‘the Company’) is scheduled to be held on Wednesday, June 24, 2020 to, inter alia, consider and approve the standalone and consolidated audited Financial Results of the Company for the quarter and financial year ended March 31, 2020.The placement and distribution of this Preliminary Placement Document is being done in reliance on chapter VI read with Schedule VII of the SEBI ICDR Regulations and section 42 of the Companies Act on a private placement basis and are meant only for QIBs that are eligible to participate in the issue and which are not excluded pursuant to regulation 179(2)(b) of the SEBI ICDR Regulations.The Book Running Lead Manager will not be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website.
The Company is headquartered in Tarrytown, NY. Prospective investors are advised to carefully read “Risk Factors” before making an investment decision relating to the issue. The Preliminary Placement Document is not and should not be construed as an invitation, offer or sale of any securities to the public in India.The information in this portion of our website, including the Placement Document, is not for publication or distribution, directly or indirectly, in or into the United States (including its territories and possessions, any state of the United States and the District of Columbia) and is not intended to be viewed by any person in the United States nor by any U.S. person (as defined in Regulation S under the U.S. Securities Act of 1933, as amended (the "Securities Act") unless such person is a "qualified institutional buyer" (as defined in Rule 144A under the Securities Act) and a "qualified purchaser" (as defined in Section 2(a)(51) of the U.S. Investment Company Act of 1940, as amended) and an institutional "accredited investor" (as defined in Rule 501(a)(1), (2), (3) or (7) of Regulation D under the Securities Act) (such person, as "Entitled Qualified Purchaser"). The Preliminary Placement Document is not intended to constitute an offer or a solicitation or invitation of an offer to subscribe to the securities to any person or class of investors other than an Eligible QIB.The Placement Document has not been and will not be filed as a prospectus with any Registrar of Companies in India under the Companies Act. Prospective investors shall conduct their own due diligence on the equity shares and the company.
Events; … The Placement Document is not and should not be construed as an invitation, offer or sale of any securities to the public in India.Click below to continue browsing our websiteThanks for giving your details. Prospective investors are advised to carefully read “Risk Factors” before making an investment decision relating to the issue.